Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection

Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection

Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidinone antibiotic with in vitro activity against some NTM, but...

Full description

Bibliographic Details
Main Authors:	Timothy David Shaw, Mark Smyth, Graham Turner, Michael Hunter
Format:	Article
Language:	English
Published:	Elsevier 2021-08-01
Series:	Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Subjects:	Non-tuberculous mycobacteria Mycobacterium chelonae Extrapulmonary infection Tedizolid
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405579421000504

Similar Items

Healthcare-Associated nontuberculous mycobacterial endocarditis following coronary artery angiography
by: Kalpak Bhatt, et al.
Published: (2023-01-01)

Successful treatment of rapid growing mycobacterial infections with source control alone: Case series
by: Igor Dumic, et al.
Published: (2021-01-01)

Successful treatment of Mycobacterium chelonae skin infection in a patient on long-term immunosuppressive therapy for myasthenia gravis
by: Işıl Göğem İmren, et al.
Published: (2021-03-01)

Biofilms of the non-tuberculous Mycobacterium chelonae form an extracellular matrix and display distinct expression patterns
by: Perla Vega-Dominguez, et al.
Published: (2020-12-01)

Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease
by: Kelly M. Pennington, et al.
Published: (2021-08-01)

Two episodes of cutaneous non-tuberculous mycobacterial infection in a patient with psoriasis
by: Wai Sze Agnes Chan, et al.
Published: (2015-06-01)

In vitro Susceptibility of Nontuberculous Mycobacteria to Tedizolid
by: Zhang H, et al.
Published: (2022-08-01)

Disseminated non-tuberculous mycobacterial infection caused by Mycobacterium obuense in an immunocompromised patient: a case report
by: Maiko Naito, et al.
Published: (2023-08-01)

Blocking ADP-ribosylation expands the anti-mycobacterial spectrum of rifamycins
by: Uday S. Ganapathy, et al.
Published: (2023-10-01)

Non-Tuberculous Mycobacterial Diseases in Children
by: Aniello Meoli, et al.
Published: (2020-07-01)

Mycobacterium chelonae causing chronic wound infection and abdominal incisional hernia
by: Susan Verghese, et al.
Published: (2014-01-01)

Cutaneous Mycobacterium chelonae infection presenting clinically as a mycetoma
by: Katie Dreher, BS, et al.
Published: (2022-01-01)

Non-tuberculous mycobacterial ocular infection masquerading as choroidal tumour – a diagnostic conundrum
by: Yeap, Khy Ching, et al.
Published: (2019-07-01)

Comparative study of in vitro activity of tedizolid and linezolid against Mycobacterium avium complex.
by: Eduardo Marfil, et al.
Published: (2022-09-01)

Cutaneous lesions induced by Mycobacterium chelonae
by: Karolina Kazimierska, et al.
Published: (2023-11-01)

Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections
by: Ferrández O, et al.
Published: (2016-12-01)

Hyperkeratotic, pruritic plaques in an incarcerated patient
by: Fareen Momin, BBA, et al.
Published: (2023-07-01)

Mycobacterium chelonae Wound Infection after Liposuction
by: Moon J. Kim, et al.
Published: (2010-07-01)

TUBERCULOUS GLOSSITIS — A RARE EXTRAPULMONARY LOCALIZATION
by: A. V. Kukurika
Published: (2021-08-01)

Comparison of the in vitro activity of linezolid, tedizolid, sutezolid, and delpazolid against rapidly growing mycobacteria isolated in Beijing, China
by: Shu’an Wen, et al.
Published: (2021-08-01)

In vitro Antimicrobial Activity Comparison of Linezolid, Tedizolid, Sutezolid and Delpazolid Against Slowly Growing Mycobacteria Isolated in Beijing, China
by: Yu X, et al.
Published: (2021-11-01)

Case studies to illustrate good practice in the management of non-tuberculous mycobacterial pulmonary disease
by: Simon Tiberi, et al.
Published: (2022-01-01)

Tolerance of Prolonged Oral Tedizolid for Prosthetic Joint Infections: Results of a Multicentre Prospective Study
by: Eric Senneville, et al.
Published: (2020-12-01)

Safety and tolerability of tedizolid as oral treatment for bone and joint infections
by: Loren G. Miller, et al.
Published: (2023-10-01)

Disseminated Mycobacterium chelonae infection in a heart transplant recipient
by: Vishal Jain, et al.
Published: (2022-01-01)

Exit Site Infection due to Mycobacterium chelonae in an Elderly Patient on Peritoneal Dialysis
by: Arata Hibi, et al.
Published: (2018-01-01)

Mycobacterium chelonae Is an Ubiquitous Atypical Mycobacterium
by: Miguel Pinto-Gouveia, et al.
Published: (2015-08-01)

Whole genome sequencing and prediction of antimicrobial susceptibilities in non-tuberculous mycobacteria
by: Priya Solanki, et al.
Published: (2022-11-01)

Tedizolid-Cyclodextrin System as Delayed-Release Drug Delivery with Antibacterial Activity
by: Magdalena Paczkowska-Walendowska, et al.
Published: (2020-12-01)

Cutaneous Mycobacterium chelonae in a Patient with Sjogren’s Syndrome
by: Guo L, et al.
Published: (2021-11-01)

Mycobacteriophages in diagnosis and alternative treatment of mycobacterial infections
by: Xudong Ouyang, et al.
Published: (2023-09-01)

Routinely detected indicators in plasma have a predictive effect on the identification of HIV-infected patients with non-tuberculous mycobacterial and tuberculous infections
by: Ren-tian Cai, et al.
Published: (2017-11-01)

The roles of neutrophils in non-tuberculous mycobacterial pulmonary disease
by: Meyad Alkarni, et al.
Published: (2023-02-01)

The Rise of Non-Tuberculosis Mycobacterial Lung Disease
by: Champa N. Ratnatunga, et al.
Published: (2020-03-01)

Clinical and microbiological characteristics of non-tuberculous mycobacteria diseases in Singapore with a focus on pulmonary disease, 2012-2016
by: Zoe Xiaozhu Zhang, et al.
Published: (2019-05-01)

A Retrospective Study to Compare the Incidence of Hyponatremia after Administration between Linezolid and Tedizolid
by: Yuichi Shibata, et al.
Published: (2023-02-01)

Mycobacterium branderi infection: Case report and literature review of an unusual and difficult-to-treat non-tuberculous mycobacterium
by: Shannon L. Turvey, et al.
Published: (2017-05-01)

Comparison of MGIT 960 with Lowenstein Jensen Media for Recovery of Mycobacteria from Extrapulmonary Specimens in Southern India
by: Kalpana Thangavelu
Published: (2021-03-01)

Whole Genome Sequencing in the Management of Non-Tuberculous Mycobacterial Infections
by: Matúš Dohál, et al.
Published: (2021-10-01)

A rare spontaneous breast abscess due to Mycobacterium chelonae: a case report
by: Yayoi Sakatoku, et al.
Published: (2023-07-01)